Credit Suisse Ag Amicus Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 322,544 shares of FOLD stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

322,544

Previous 326,217 1.13%

Holding current value

$3.12 Million

Previous $4.63 Million 17.93%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$11.43 - $14.24 $41,982 - $52,303	-3,673 Reduced 1.13%	322,544 $3.8 Million
Q4 2023 Feb 08, 2024	SELL	$9.97 - $14.52 $947 - $1,379	-95 Reduced 0.03%	326,217 $4.63 Million
Q3 2023 Nov 13, 2023	SELL	$11.78 - $13.86 $380,965 - $448,232	-32,340 Reduced 9.02%	326,312 $3.97 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $720,791 - $894,265	67,238 Added 23.07%	358,652 $4.5 Million
Q1 2023 May 10, 2023	BUY	$10.91 - $13.54 $170,872 - $212,063	15,662 Added 5.68%	291,414 $3.23 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $65,333 - $83,896	6,606 Added 2.45%	275,752 $3.37 Million
Q3 2022 Nov 10, 2022	BUY	$9.82 - $12.75 $135,201 - $175,542	13,768 Added 5.39%	269,146 $2.81 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $11.12 $85,880 - $153,289	-13,785 Reduced 5.12%	255,378 $2.74 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $267,944 - $423,820	33,960 Added 14.44%	269,163 $2.55 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $99,309 - $125,805	-10,113 Reduced 4.12%	235,203 $2.72 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $190,164 - $257,614	-21,758 Reduced 8.15%	245,316 $2.34 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $17,541 - $21,590	2,014 Added 0.76%	267,074 $2.58 Million
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $1.31 Million - $3.4 Million	-142,326 Reduced 34.94%	265,060 $2.62 Million
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $914,033 - $1.69 Million	67,857 Added 19.99%	407,386 $9.41 Million
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $1.63 Million - $2.01 Million	-126,794 Reduced 27.19%	339,529 $4.79 Million
Q2 2020 Aug 12, 2020	BUY	$8.86 - $15.69 $1.51 Million - $2.67 Million	170,039 Added 57.39%	466,323 $7.03 Million
Q1 2020 May 13, 2020	SELL	$6.63 - $11.16 $269,867 - $454,256	-40,704 Reduced 12.08%	296,284 $2.74 Million
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $999,021 - $1.44 Million	133,559 Added 65.65%	336,988 $3.28 Million
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $57,214 - $94,525	7,134 Added 3.63%	203,429 $1.63 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $333,556 - $438,249	30,434 Added 18.35%	196,295 $2.45 Million
Q1 2019 May 14, 2019	SELL	$10.04 - $13.92 $306,199 - $424,532	-30,498 Reduced 15.53%	165,861 $2.26 Million
Q4 2018 Feb 13, 2019	BUY	$8.38 - $13.44 $93,462 - $149,896	11,153 Added 6.02%	196,359 $1.88 Million
Q3 2018 Nov 13, 2018	SELL	$11.6 - $16.54 $373,694 - $532,836	-32,215 Reduced 14.82%	185,206 $2.24 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $4.01 Million - $5.21 Million	-305,048 Reduced 58.39%	217,421 $3.4 Million
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $2.25 Million - $2.8 Million	-163,372 Reduced 23.82%	522,469 $7.86 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $2.85 Million - $3.7 Million	-227,901 Reduced 24.94%	685,841 $9.87 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $8.91 Million - $12 Million	759,307 Added 491.67%	913,742 $13.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	154,435	154,435 $1.55 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account